Catalyst Wire Dossier Catalyst Wire Dossier

Pyrrolidinamide

Pyrrolidinamide · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pyrrolidinamide, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria [Phase 2]

See pricing